• +1-646-491-9876
    • +91-20-67278686

    Search

    Alopecia-Pipeline Review H2 2017

    Alopecia-Pipeline Review H2 2017

    • Report Code ID: RW0001881442
    • Category Life Sciences
    • No. of Pages 143
    • Publication Month Jul-17
    • Publisher Name Global Markets Direct
    Alopecia-Pipeline Review H2 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia-Pipeline Review H2 2017 provides an overview of the Alopecia (Dermatology) pipeline landscape.

    Alopecia is the partial or complete loss of hair especially on the scalp either in patches on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies irritants toxins burns injuries and infections.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Alopecia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Alopecia (Dermatology) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.

    The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Pre-Registration Phase III Phase II Phase I IND/CTA Filed Preclinical and Discovery stages are 1 1 12 5 1 19 and 9 respectively. Similarly the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules respectively.

    Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology) .
    - The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)

    Reasons to buy

    - Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    List of Tables 4
    List of Figures 5
    Introduction 6
    Publisher Report Coverage 6
    Alopecia-Overview 7
    Alopecia-Therapeutics Development 8
    Pipeline Overview 8
    Pipeline by Companies 9
    Pipeline by Universities/Institutes 12
    Products under Development by Companies 13
    Products under Development by Universities/Institutes 16
    Alopecia-Therapeutics Assessment 17
    Assessment by Target 17
    Assessment by Mechanism of Action 20
    Assessment by Route of Administration 23
    Assessment by Molecule Type 25
    Alopecia-Companies Involved in Therapeutics Development 27
    Aclaris Therapeutics Inc 27
    Allergan Plc 27
    Almirall SA 28
    AndroScience Corp 28
    Berg LLC 29
    BiologicsMD Inc 29
    BirchBioMed Inc 30
    Brickell Biotech Inc 30
    Bristol-Myers Squibb Company 31
    Cassiopea SpA 31
    Daewoong Pharmaceutical Co Ltd 32
    Dong-A Socio Holdings Co Ltd 32
    Handok Inc 33
    Histogen Inc 33
    Hyundai Pharmaceutical Co Ltd 34
    Incyte Corp 34
    Kuhnil Pharmaceutical Co Ltd 35
    Lee's Pharmaceutical Holdings Ltd 35
    LEO Pharma A/S 36
    Medivir AB 36
    NovaLead Pharma Pvt Ltd 37
    Panacea Biotec Ltd 37
    Pfizer Inc 38
    Quark Pharmaceuticals Inc 38
    RXi Pharmaceuticals Corp 39
    Samumed LLC 39
    Switch Biotech LLC 40
    Taisho Pharmaceutical Holdings Co Ltd 40
    Tigo GmbH 41
    viDA Therapeutics Inc 41
    Alopecia-Drug Profiles 42
    (cyclosporine A + minoxidil + RT-175)-Drug Profile 42
    abatacept-Drug Profile 43
    AI-001-Drug Profile 51
    Antibodies to Inhibit Heparanase for Alopecia Colitis Diabetic Nephropathy Transplantation and Oncology-Drug Profile 52
    Antisense Oligonucleotide to Inhibit Androgen Receptor for Alopecia-Drug Profile 53
    ASCJ-9-Drug Profile 54
    ATI-50001-Drug Profile 56
    ATI-50002-Drug Profile 57
    ATI-50003-Drug Profile 58
    BBI-5000-Drug Profile 59
    BMD-1141-Drug Profile 60
    BMD-1341-Drug Profile 61
    BMD-2341-Drug Profile 62
    BQ-A-Drug Profile 63
    BRM-421-Drug Profile 64
    calcitriol-Drug Profile 65
    CB-0301-Drug Profile 66
    DHL-HisZnNa-Drug Profile 69
    finasteride-Drug Profile 70
    finasteride-Drug Profile 71
    FOL-005-Drug Profile 72
    HGEN-001-Drug Profile 75
    HL-5945-Drug Profile 77
    HTB-005-Drug Profile 78
    interferon beta-1b-Drug Profile 79
    KI-1104-Drug Profile 80
    KI-1105-Drug Profile 81
    LEO-124249-Drug Profile 82
    minoxidil-Drug Profile 83
    NLP-602-Drug Profile 84
    OLX-104-Drug Profile 85
    PF-06651600-Drug Profile 86
    PF-06700841-Drug Profile 87
    QPAL-1-Drug Profile 89
    QPAL-2-Drug Profile 90
    RBAG-010-Drug Profile 91
    Recombinant Proteins to Agonize EGFR for Alopecia and Arthritis-Drug Profile 92
    Recombinant Proteins to Antagonize IFN-Gamma Receptor 1 for Alopecia Areata and Graft Arteriosclerosis-Drug Profile 93
    remetinostat-Drug Profile 94
    ruxolitinib phosphate-Drug Profile 97
    Samcyprone-Drug Profile 112
    setipiprant-Drug Profile 114
    SM-04554-Drug Profile 116
    Small Molecule for Androgenic Alopecia-Drug Profile 119
    Small Molecules to Inhibit JAK for Alopecia Areata Androgenetic Alopecia and Dermatological Disorders-Drug Profile 120
    Synthetic Peptide for Alopecia-Drug Profile 121
    TP-0427736-Drug Profile 122
    TS-133-Drug Profile 123
    VTI-1000 Series-Drug Profile 124
    ZK-003-Drug Profile 125
    Alopecia-Dormant Projects 126
    Alopecia-Discontinued Products 128
    Alopecia-Product Development Milestones 129
    Featured News & Press Releases 129
    Appendix 138
    Methodology 138
    Coverage 138
    Secondary Research 138
    Primary Research 138
    Expert Panel Validation 138
    Contact Us 138
    Disclaimer 139

    List of Tables

    Number of Products under Development for Alopecia H2 2017
    Number of Products under Development by Companies H2 2017
    Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017
    Number of Products under Development by Universities/Institutes H2 2017
    Products under Development by Companies H2 2017
    Products under Development by Companies H2 2017 (Contd..1) H2 2017
    Products under Development by Companies H2 2017 (Contd..2) H2 2017
    Products under Development by Universities/Institutes H2 2017
    Number of Products by Stage and Target H2 2017
    Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017
    Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017
    Number of Products by Stage and Route of Administration H2 2017
    Number of Products by Stage and Molecule Type H2 2017
    Alopecia-Pipeline by Aclaris Therapeutics Inc H2 2017
    Alopecia-Pipeline by Allergan Plc H2 2017
    Alopecia-Pipeline by Almirall SA H2 2017
    Alopecia-Pipeline by AndroScience Corp H2 2017
    Alopecia-Pipeline by Berg LLC H2 2017
    Alopecia-Pipeline by BiologicsMD Inc H2 2017
    Alopecia-Pipeline by BirchBioMed Inc H2 2017
    Alopecia-Pipeline by Brickell Biotech Inc H2 2017
    Alopecia-Pipeline by Bristol-Myers Squibb Company H2 2017
    Alopecia-Pipeline by Cassiopea SpA H2 2017
    Alopecia-Pipeline by Daewoong Pharmaceutical Co Ltd H2 2017
    Alopecia-Pipeline by Dong-A Socio Holdings Co Ltd H2 2017
    Alopecia-Pipeline by Handok Inc H2 2017
    Alopecia-Pipeline by Histogen Inc H2 2017
    Alopecia-Pipeline by Hyundai Pharmaceutical Co Ltd H2 2017
    Alopecia-Pipeline by Incyte Corp H2 2017
    Alopecia-Pipeline by Kuhnil Pharmaceutical Co Ltd H2 2017
    Alopecia-Pipeline by Lee's Pharmaceutical Holdings Ltd H2 2017
    Alopecia-Pipeline by LEO Pharma A/S H2 2017
    Alopecia-Pipeline by Medivir AB H2 2017
    Alopecia-Pipeline by NovaLead Pharma Pvt Ltd H2 2017
    Alopecia-Pipeline by Panacea Biotec Ltd H2 2017
    Alopecia-Pipeline by Pfizer Inc H2 2017
    Alopecia-Pipeline by Quark Pharmaceuticals Inc H2 2017
    Alopecia-Pipeline by RXi Pharmaceuticals Corp H2 2017
    Alopecia-Pipeline by Samumed LLC H2 2017
    Alopecia-Pipeline by Switch Biotech LLC H2 2017
    Alopecia-Pipeline by Taisho Pharmaceutical Holdings Co Ltd H2 2017
    Alopecia-Pipeline by Tigo GmbH H2 2017
    Alopecia-Pipeline by viDA Therapeutics Inc H2 2017
    Alopecia-Dormant Projects H2 2017
    Alopecia-Dormant Projects H2 2017 (Contd..1) H2 2017
    Alopecia-Discontinued Products H2 2017

    List of Figures

    Number of Products under Development for Alopecia H2 2017
    Number of Products under Development by Companies H2 2017
    Number of Products under Development by Universities/Institutes H2 2017
    Number of Products by Top 10 Targets H2 2017
    Number of Products by Stage and Top 10 Targets H2 2017
    Number of Products by Top 10 Mechanism of Actions H2 2017
    Number of Products by Stage and Top 10 Mechanism of Actions H2 2017
    Number of Products by Routes of Administration H2 2017
    Number of Products by Stage and Routes of Administration H2 2017
    Number of Products by Top 10 Molecule Types H2 2017
    Number of Products by Stage and Top 10 Molecule Types H2 2017
    Aclaris Therapeutics Inc
    Allergan Plc
    Almirall SA
    AndroScience Corp
    Berg LLC
    BiologicsMD Inc
    BirchBioMed Inc
    Brickell Biotech Inc
    Bristol-Myers Squibb Company
    Cassiopea SpA
    Daewoong Pharmaceutical Co Ltd
    Dong-A Socio Holdings Co Ltd
    Handok Inc
    Histogen Inc
    Hyundai Pharmaceutical Co Ltd
    Incyte Corp
    Kuhnil Pharmaceutical Co Ltd
    Lee's Pharmaceutical Holdings Ltd
    LEO Pharma A/S
    Medivir AB
    NovaLead Pharma Pvt Ltd
    Panacea Biotec Ltd
    Pfizer Inc
    Quark Pharmaceuticals Inc
    RXi Pharmaceuticals Corp
    Samumed LLC
    Switch Biotech LLC
    Taisho Pharmaceutical Holdings Co Ltd
    Tigo GmbH
    viDA Therapeutics Inc

    Request for Sample

    Report Url http://www.reportsweb.com//alopecia-pipeline-review-h2-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//alopecia-pipeline-review-h2-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//alopecia-pipeline-review-h2-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments